Rebecca Taub

2016

In 2016, Rebecca Taub earned a total compensation of $1.7M as Chief Medical Officer, Executive Vice President, Research & Development at Synta Pharmaceuticals.

Compensation breakdown

Bonus$62,160
Option Awards$1,139,272
Salary$162,705
Stock Awards$289,416
Other$465
Total$1,654,018

Taub received $1.1M in option awards, accounting for 69% of the total pay in 2016.

Taub also received $62.2K in bonus, $162.7K in salary, $289.4K in stock awards and $465 in other compensation.

Rankings

In 2016, Rebecca Taub's compensation ranked 5,791st out of 14,075 executives tracked by ExecPay. In other words, Taub earned more than 58.9% of executives.

ClassificationRankingPercentile
All
5,791
out of 14,075
59th
Division
Manufacturing
2,102
out of 5,486
62nd
Major group
Chemicals And Allied Products
684
out of 1,900
64th
Industry group
Drugs
513
out of 1,543
67th
Industry
Pharmaceutical Preparations
408
out of 1,173
65th
Source: SEC filing on April 27, 2018.

Taub's colleagues

We found two more compensation records of executives who worked with Rebecca Taub at Synta Pharmaceuticals in 2016.

2016

Paul Friedman

Synta Pharmaceuticals

Chief Executive Officer

2016

Marc Schneebaum

Synta Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like